Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Palliative care has not traditionally been seen as applicable to patients who are candidates for device-based therapies, including transcatheter aortic valve replacement (TAVR) and ventricular assist devices (VADs). However, although improvements in technology, expertise at implanting devices, and patient selection have been made,1 these devices come with a risk of morbid complications that can be particularly deleterious in elderly patients with preexisting comorbidities and impaired baseline functional and/or cognitive status.2 Therefore, we designed a survey of clinicians (physicians, nurses, and advanced practice practitioners) to assess attitudes toward and current status of palliative care in the approach to patients undergoing TAVR and VAD implantation procedures.
Kirkpatrick JN, Hauptman PJ, Swetz KM, Blume ED, Gauvreau K, Maurer M, Goodlin SJ. Palliative Care for Patients With End-Stage Cardiovascular Disease and DevicesA Report From the Palliative Care Working Group of the Geriatrics Section of the American College of Cardiology. JAMA Intern Med. 2016;176(7):1017-1019. doi:10.1001/jamainternmed.2016.2096